PRECIGEN, INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
PRECIGEN, INC. (PGEN) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 79.71 million shares for the 1-month period ending 2013-08-13, per its 10-Q filed 2013-11-07.
Discontinued › Shareholders' Equity › Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2016-02-29
- 2013-08-13: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 79.71M shares; Stock Issued During Period, Shares, Conversion of Convertible Securities 79.71M shares; Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 79.71M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month | Stock Issued During Period, Shares, Conversion of Convertible Securities | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|---|---|
| 2013-08-13 | 79.71M shares 10-K · filed 2016-02-29 | 79.71M shares 10-Q · filed 2014-11-13 | 79.71M shares 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |